 |
 |
Ken, I believe what you are referring to is the selegiline patch that Somerset is working on. It is still in the development stage. Check out http://www.somersetpharm.com/corporate/profile.html. However, to save you some time, here is a direct quote: " Somerset is currently engaged in the clinical development of a selegiline transdermal system for the treatment of several indications, including Alzheimer's disease, Depression and Parkinson's Disease."